莱博科 LH
$366.57 +$3.27 (+0.90%)
休市 · Nov 6, 9:50 pm ET · 最新盘后价 $366.57 0.00%
开盘$357.25
昨收$363.30
当日区间$355.63 – $369.06
成交量610.1K
市值$29.77B
市盈率（TTM）30.0
股息率0.79%
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例102.1%-1.04 个百分点，较上季度
持仓机构数1,273+14 ，较上季度
内部人近期交易17次买入 / 33次卖出净卖出
空头持仓比例3.15% 占流通股回补天数 4.2 · 截至 15 Oct 2026
卖空成交量占比14.0%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$7.52M（10个净流入日，10个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有30.6%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从2.59%升至3.15%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Deka Investment GmbH | Mutual Fund | 2026/Q3 | +284,595 | 0.6% |
| Citigroup Inc. | Public Company | 2026/Q3 | +72,277 | 0.2% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +682,894 | 3.8% |
| FMR | Mutual Fund | 2026/Q3 | +620,714 | 2.3% |
| Amundi Asset Management | Mutual Fund | 2026/Q3 | +322,339 | 0.7% |
| Victory Capital Management Inc. | Mutual Fund | 2026/Q3 | +210,447 | 6.0% |
| EARNEST Partners, LLC | Mutual Fund | 2026/Q3 | +163,433 | 0.6% |
| BlackRock | Mutual Fund | 2026/Q3 | +129,405 | 8.1% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +118,273 | 0.3% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +110,275 | 0.7% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +103,470 | 0.3% |
| Bessemer Investment Management LLC | Mutual Fund | 2026/Q3 | +96,598 | 0.8% |
| Marshall Wace LLP | Hedge Fund | 2026/Q3 | +92,767 | 0.1% |
| Managed Account Advisors LLC | Mutual Fund | 2026/Q3 | +89,310 | 0.5% |
| River Road Asset Management, LLC | Mutual Fund | 2026/Q3 | +84,153 | 0.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 31 Aug 2026 | Brian Caveney | Exec VP, President of Biopharma Laboratory Services & Chief Medical and Scientific Officer | Other Derivative Acquisition | +3,000 | – | 7,170 |
| 31 Aug 2026 | Akinbolade Oyegunwa | Executive VP and Chief Information & Technology Officer | Other Derivative Acquisition | +750 | – | 2,940 |
| 31 Aug 2026 | Jonathan Meltzer | Chief Operating Officer | Other Derivative Acquisition | +900 | – | 3,594 |
| 31 Aug 2026 | Bryan Vaughn | Executive VP & President of Diagnostics | Other Derivative Acquisition | +1,500 | – | 5,204 |
| 16 Aug 2026 | Kerrii Anderson | Independent Director | Automatic Disposition | -3,000 | $318.02 | 6,851 |
| 10 Aug 2026 | Adam Schechter | Chairperson & CEO | Automatic Disposition | -4,669 | $320.37 | 102,565 |
| 3 Aug 2026 | Amy Summy | Executive VP, Chief Marketing Officer & Consumer Health Lead | Open Market Disposition | -924 | $306.74 | 6,956 |
| 2 Aug 2026 | Peter Wilkinson | Chief Accounting Officer | Open Market Disposition | -82 | $309.22 | 1,770 |
| 2 Aug 2026 | Peter Wilkinson | Chief Accounting Officer | Derivative Exercise and Sale | -1,338 | $309.23 | 1,770 |
| 1 Jul 2026 | Kathryn Kyle | Executive Vice President | Intent to Sell (Form 144) | -92 | $286.19 | – |
| 1 Jul 2026 | Bryan Vaughn | Executive VP & President of Diagnostics | Intent to Sell (Form 144) | -234 | $286.19 | – |
| 1 Jul 2026 | Kathryn Kyle | Executive Vice President | Derivative Exercise and Sale | -165 | $286.19 | 3,904 |
| 1 Jul 2026 | Bryan Vaughn | Executive VP & President of Diagnostics | Derivative Exercise and Sale | -327 | $286.19 | 6,746 |
| 30 Jun 2026 | Sandra van der Vaart | Former EVP, Corporate Affairs and Assistant Secretary | Intent to Sell (Form 144) | -7,138 | $280.48 | – |
| 30 Jun 2026 | Kathryn Kyle | Executive Vice President | Derivative Exercise and Retained | +91 | – | 3,904 |
| 7 Jun 2026 | Kathryn Kyle | Executive Vice President | Automatic Disposition | -762 | $263.89 | 3,813 |
| 10 May 2026 | Adam Schechter | Chairperson & CEO | Automatic Disposition | -5,903 | $254.50 | 107,234 |
| 5 May 2026 | Sandra van der Vaart | Former EVP, Corporate Affairs and Assistant Secretary | Intent to Sell (Form 144) | -6,238 | $256.76 | – |
| 26 Mar 2026 | Peter Wilkinson | Chief Accounting Officer | Automatic Disposition | -1,633 | $267.05 | 1,852 |
| 26 Mar 2026 | Jonathan Meltzer | Chief Operating Officer | Automatic Disposition | -839 | $267.05 | 3,620 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 2,557,656 | 3.2% | 4.2 |
| 30 Sep 2026 | 2,684,363 | 3.3% | 3.0 |
| 15 Sep 2026 | 2,448,617 | 3.0% | 3.3 |
| 31 Aug 2026 | 2,103,302 | 2.6% | 3.2 |
| 14 Aug 2026 | 1,938,163 | 2.4% | 3.8 |
| 31 Jul 2026 | 2,094,544 | 2.6% | 2.2 |
暂无评论——快来第一个聊聊 LH。
登录后参与讨论。